THE HEART SHOT
By Craig Paardekooper

Data source for blue tables :here

Data source for red tables :here

Background :here

Myocarditis

The incidence of myocarditis with mRNA vaccines such as Comirnaty, Tozinameran,Moderna and Spikevax is much higher than the incidence with adenovirus vector
vaccines such as Vaxzevria / Astrazeneca. The risk is 10 x greater with mRNA
vaccines.
Reporting Incidence is 0.3% with mRNA, and 0.03% with adenovirus vector
vaccines. The Proportional Reporting Ratio for myocarditis with Comirnaty is3.65 meaning that the incidence is 3.65 times higher than the average for allother drugs. Viral-vector jabs are highlighted in yellow.

These are the lower confidence limits of the PRR scores for myocarditis. Noticethat Comirnaty, Spikevax and Tozinameran are all mRNA jabs.

Viral-Vector jabs such as
Vaxzevria / Astrazeneca arecompletely absent, andtherefore do not generate any
safety signal for myocarditis.

Pericarditis

The incidence of pericarditis with mRNA vaccines such as Comirnaty,Tozinameran, Moderna and Spikevax is much higher than the incidence withadenovirus vector vaccines such as Vaxzevria / Astrazeneca. The risk is 10 x
greater with mRNA vaccines.
Reporting Incidence is 0.3% with mRNA, and 0.03% with adenovirus vector
vaccines.

These are the lower confidence limits of the PRR scores for pericarditis.
Notice that Comirnaty, Tozinameran, Moderna and Spikevax are all mRNA jabs.
Viral-vector jabs such as Vaxzevria are completely absent.

Viral-Vector jabs such as Vaxzevria / Astrazeneca are completely absent, andtherefore do not generate any safety signal for myocarditis or pericarditis.

Myopericarditis

For some reason, mRNA Covid shots were attacking the heart BUT adenovirus Covid
shots were not.
If mRNA Covid jabs have 10x the incidence of cardiac issues compared to adenovirus vector jabs, then they will account for about 90 % of the cases ofmyocarditis, pericarditis and myopericarditis.
These are the lower confidence limits of the PRR scores for pericarditis.
Notice that Comirnaty, Tozinameran, Moderna and Spikevax are all mRNA jabs.
Viral-vector jabs such as Vaxzevria \ Astrazeneca are completely absent andtherefore do not generate a safety signal for myopericarditis.

Chest Pain

The only vaccine generating a safety signal (where PRR > 2) is Tozinameran (thebrand name for Comirnaty batches that were shipped abroad)
Notice that the reported incidence rate is 1.18% which is double that for theviral-vector vaccine Vaxzevria.

Only Tozinameran (an mRNA vaccine) has a safety signal for chest pain.

Cardiac Discomfort

When we look at the lower confidence limits for these PRR scores, JCovden drops
out because of its small sample size.

Comirnaty and Spikevax (both mRNA vaccines) are the only two that generate asafety signal for “cardiac discomfort”. JCovden drops out because in the pinttables (online search engine) the minimum number of symptom records must be >=10.

Palpitations

Only Tozinameran and Comirnaty generate a safety signal (where PRR > 2). Noticethat the reported incidence rate for Tozinameran is 0.827 % (1 in 120)

Arrhythmia

Only JCovden and Comirnaty generate a safety signal (where PRR > 2)

Tachycardia

Only JCovden and Comirnaty generate a safety signal (where PRR > 2)

Cardiac Flutter

Only Tozinameran generates a safety signal (where PRR > 2)

There are a number of tests used as biomarkers for myocarditis. These include –1. Troponin
2. Echocardiogram
3. Electrocardiogram with ST Segment Elevation
4. Magnetic Resonance Imaging of the Heart

Troponin

The score here is for all symptoms that include the word “troponin”

The only vaccine generating a safety signal (where PRR > 2) is Spikevax

Troponin Abnormal

Only Comirnaty (an mRNA vaccine) generates a safety signal for “troponinabnormal”

Troponin Increased

Even though the lower confidence limit of the PRR is less than 2 for Comirnaty(an mRNA vaccine), it is a very close call.

Troponin i

Spikevax (an mRNA vaccine) has a strong safety signal for “troponin i”

Troponin t

Comirnaty (an mRNA vaccine) has a strong safety signal for “troponin t
increased”

EchocardiogramEchocardiogram Abnormal

Electrocardiogram ST Segment Elevation

Only Comirnaty, an mRNA Covid jab, generates a significant increase in thissymptom.

Magnetic Resonance Imaging HeartSo, with the exception of cardiac rhythm effects produced by JCovden, the great
majority of cardiac adverse reactions are generated following mRNA jabs.
Astrazeneca, and Vaxzevria are completely absent of these effects.

What are the Most Common Symptoms of Cardiac Disorder?
Chest pain, Tachycardia and Palpitations are the most common symptoms occurringin 0.5 – 1% of reported cases for mRNA vaccines depending upon brand.
Myocarditis or pericarditis develop in about a third of these cases.

Cardiac and Neurological Complications Post COVID-19 Vaccination: A Systematic
Review of Case Reports and Case Series
https://www.mdpi.com/2076-393X/12/6/575
by Kai Wei Lee, Sook Fan Yap, Syafinaz Amin-Nordin and Yun Fong Ngeow
Vaccines 2024, 12(6), 575;
https://doi.org/10.3390/vaccines12060575
Published: 24 May 2024

"Abstract
Following mass vaccinations for the control of the COVID-19 epidemic, aspectrum of cardiac and neurological disorders was reported among vaccinatedindividuals. This study examined the range of complications documented andfactors related to their occurrence. Three electronic databases weresearched for case reports and case series with descriptions of cardiacand/or neurological complications in COVID-19 vaccine recipients. A totalof 698 vaccinees were included in this review, of which 259 (37.1%) had
cardiac and 439 (62.9%) had neurological complications. Inflammatory
conditions were the commonest among the cardiac complications; while
polyneuropathy, demyelinating diseases and cerebrovascular disorders werethe more common neurological complications. The mean age of those withcardiac complications (33.8 years) was much younger than those withneurological complications (49.7 years). There was no notable differencein the gender distribution between these two groups of vaccine recipients.
mRNA vaccines (all brands) were associated with almost 90.0% of the cardiac
complications, whereas viral vector vaccines were associated with slightly
over half (52.6%) of the neurological complications. With regard to thedose, cardiac complications were more common after the second (69.1%),
whereas neurological complications were more common after the first dose
(63.6%). The majority of the cases had an uncomplicated clinical course.
Nevertheless, 5.9% of cases with neurological complications and 2.5% of
those with cardiac complications were fatal, underscoring the significanceof the consistent surveillance and vigilant monitoring of vaccinatedindividuals to mitigate these occurrences."

This paper shows that mRNA Covid jabs were associated with almost 90% of thecardiac complications.

Complications following the administration of approved vaccines have beenreported worldwide [1]. These complications affected different organsystems, two of the most widely recognized being the cardiovascular andnervous systems. The most common cardiac complication reported was
myocarditis [2], while the neurological complications most often reported
included Guillain–Barré syndrome (GBS) [3], transverse myelitis [4] andBell palsy [5].

Types of Cardiac Injury
•
••
•
•

Inflammation of the heart
Acute myocardial infarction
Cardiomyopathy
Myocardial injury
Arrhythmia

85.3% or 221 cases
5.8%
4.2%
3.5%
1.2%

Sub-categories for Inflammation of the Heart•••••

myocarditis
myopericarditis
pericarditis
kounis syndrome
non-specific inflammation

68.77 % or 152/221 cases
17.19 % or 38/221 cases
9.95 % or 22/221 cases
1.3% or 3/221 cases
2.7% or 6/221 cases% of Cases of Cardiac injury caused by each type of vaccine
•••

mRNA
Viral vector vaccines
Inactivated vaccines

90% of the cases of cardiac injury
8.55 % of the cases of cardiac injury
1.5% of the cases of vaccine injury% of Cases of Cardiac injury associated with each brand of mRNA vaccine•••

PfizerModerna
Other mRNA vaccines

62.2%
25.5%
2.3%

Neurological Disorders
Regarding the cases of neurological disorder –Slightly more than half (53.6%) received viral vector vaccines, 42.1%
received mRNA vaccines, and a small number (4.4%) received inactivatedvaccines.
Once again, inactivated vaccines were associated with the least number of cases.